Published in Cancer Weekly, September 16th, 2003
"The oncogenic properties of the principal EBV oncoprotein, latent membrane protein 1 (LMP-1), include the ability to induce invasiveness and metastasis factors. We have shown that IMP-1 induces matrix metalloproteinase 9 (MMP-9), a type IV collagenase that disrupts basement membrane. Also, cycloaxygenase-2 (COX-2), which is overexpressed in diverse malignancies, is induced by LMP-1; the enzyme is functional, and co-expressed with LMP-1 in NPC." scientists in the United States report.
"Inhibitors of the NFxB signaling pathway, which is activated by LMP-1, including IxB super-repressor...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.